Chemical Compound

Metaproterenol sulfate

CAS Registry Number 5874-97-5

Back to search Request a Quote

Primary Record

Metaproterenol sulfate

In stock: 3,637 g
Purity: 99.0 %
CAS: 5874-97-5

Compound Identifiers & Properties

CAS: 5874-97-5
PubChem CID: 441333
SMILES: CC(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O
Canonical SMILES: CC(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O

Names & Synonyms

Metaproterenol sulfate
Orciprenaline sulfate
Metaproterenol hemisulfate salt
Metaproterenol hemisulfate
Alupent
Prometa
Novasmasol
Orciprenaline sulphate
Metaproterenol sulphate
Metaprel
5874-97-5
Alotec
Alupent obstetric
Prestwick_845
Alupent (TN)
ORCIPRENALINE
dl-Orciprenaline sulfate
RefChem:56514
Orciprenaline (hemisulfate)
dl-Metaproterenol sulfate
AC1L9AZJ
AC1Q7DNI
Metaproterenol (hemisulfate)
Orciprenaline sulfate CRS
DTXSID4045391
Norepinephrine Impurity 35
Metaproterenol sulfate [USAN]
GJ20H50YF0
(+-)-Orciprenaline sulfate
UNII-GJ20H50YF0
SCHEMBL41815
TH-152
DTXCID2025391
Metaproterenol sulfate (USP)
C22H36N2O10S
Orciprenaline sulfate (JP18)
MSK1376A
orb1310766
CHEMBL1568057
CHEBI:83332
CTK8A7112
MFCD00058303
MKFFGUZYVNDHIH-UHFFFAOYSA-N
HMS1569F11
HMS2096F11
HMS3262C10
HMS3713F11
HMS5083I11
METAPROTERENOL SULFATE [MI]
ORCIPRENALINE SULFATE [JAN]
BCP13601
Metaproterenol sulfate [USAN:USP]
Orciprenaline for system suitability
EINECS 227-539-6
MSK1376A-1000M
Tox21_110551
Tox21_500734
CID441333
EBC-15025
ORCIPRENALINE HEMISULFATE SALT
C11H17NO3.1/2H2O4S
METAPROTERENOL SULFATE [VANDF]
Orciprenaline sulfate (2:1) (salt)
ORCIPRENALINE SULFATE [MART.]
AKOS015994757
Metaproterenol sulfate (2:1) (salt)
ORCIPRENALINE SULFATE [WHO-DD]
Tox21_110551_1
CCG-220505
CCG-222038
CS-O-30996
LP00734
METAPROTERENOL SULFATE [USP-RS]
SS-4263
Orciprenaline for system suitability CRS
Metaproterenol sulfate, orciprenaline sulfate
NCGC00015655-09
NCGC00016662-01
NCGC00094078-01
NCGC00261419-01
O694
CAS-5874-97-5
DB-053257
METAPROTERENOL SULFATE [ORANGE BOOK]
ORCIPRENALINE SULFATE [EP MONOGRAPH]
EU-0100734
FT-0628263
SW198971-2
C11-H17-N-O3.1/2H2-O4-S
EN300-50867
METAPROTERENOL SULFATE [USP MONOGRAPH]
D00685
F82060
M 2398
874M975
Metaproterenol sulfate;Th-152; Th 152; Th152
SR-01000872665
1-(3,5-Dihydroxyphenyl)-2-(isopropylamino)ethanol sulfate
SR-01000872665-1
Q27279120
1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane sulfate
Z955123630
3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol sulfate
5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric acid
bis(5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol); sulfuric acid
1-(3 5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane sulfate
bis(5-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol) sulfate
Metaproterenol hemisulfate salt Solution in Methanol, 1000ug/mL
3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol sulfate (2:1)
5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol;sulfuric acid
5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol; sulfuric acid
Metaproterenol sulfate, United States Pharmacopeia (USP) Reference Standard
Orciprenaline sulfate, European Pharmacopoeia (EP) Reference Standard
(+/-)-3,5-DIHYDROXY-.ALPHA.-((ISOPROPYLAMINO)METHYL)BENZYL ALCOHOL SULFATE (2:1)
(+/-)-3,5-DIHYDROXY-.ALPHA.-((ISOPROPYLAMINO)METHYL)BENZYL ALCOHOL SULPHATE (2:1)
1,3-Bencenodiol, 5-[1-hidroxi-2-[(1-metiletil)amino]etil]-, sulfato (2:1)
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, sulfate (2:1) (salt)
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, sulfate (2:1) salt
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate(2:1)(Salt)
1,3-benzenediol, 5-[1-hidroxi-2-[(1-metil) amino] etil]-, sulfato (2:1) (sal) (9CI)
1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, sulfate (2:1) (salt)
13-Benzenediol 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-sulfate (2:1) (salt) (9CI)
3 5-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol sulfate (2:1) (salt)
5-((1RS)-1-Hydroxy-2-((1-methylethyl)amino)ethyl)benzene-1,3-diol hemisulfate
Benzyl alcohol, 3,5-dihydroxy-.alpha.-[(isopropylamino)methyl]-, sulfate (2:1) (salt)
Benzyl alcohol35-dihydroxy-alpha-[(isopropylamino)methyl]-sulfate (2:1) (salt) (8CI)
bis(5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol); sulfuric acid
Orciprenaline for system suitability, European Pharmacopoeia (EP) Reference Standard
Sulfuric acid--5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol (1/2)
1,3-BENZENEDIOL, 5-(1-HYDROXY-2-(1-METHYLETHYL)AMINO)ETHYL-, (+/-)-, SULFATE (2:1) (SALT)
1,3-BENZENEDIOL, 5-(1-HYDROXY-2-(1-METHYLETHYL)AMINO)ETHYL-, (+/-)-, SULPHATE (2:1) (SALT)
1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, sulfate (2:1); 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane sulfate; Alotec; Alupent; Astmopent; Metaprel; Metaproterenol hemisulfate; Metaproterenol sulfate; Metaproterenol sulfate (2:1) (salt); Novasmasol; Orciprenaline sulfate; Orciprenaline sulfate (2:1) (salt); Th 152; dl-Metaproterenol sulfate; dl-Orciprenaline sulfate, Bis[5-[(1RS)-1-hydroxy-2-[(1-methylethyl)amino]ethyl]benzene-1,3-diol] sulfate; Benzyl alcohol, 3,5-dihydroxy-alpha-[(isopropylamino)methyl]-, sulfate (2:1) (salt) (8CI); (+/-)-Orciprenaline sulfate; 3,5-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol sulfate (2:1) (salt)
227-539-6
Metaproterenol sulfate; 1,3-Benzenediol, 5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, sulfate (2:1)